Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/426—1,3-Thiazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/14—Antivirals for RNA viruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/20—Antivirals for DNA viruses
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/02—Antineoplastic agents specific for leukemia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/04—Antineoplastic agents specific for metastasis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
  • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
  • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D277/38—Nitrogen atoms
  • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
  • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
  • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
  • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
  • C07D487/04—Ortho-condensed systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
  • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
  • C07D495/04—Ortho-condensed systems
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
  • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

• T t most meetit dais sdasafe tliai 1 ⁇ 2 fa wess sases of Ik aad lasle « c£ sa-soss of sissfe fee £HOC3 ⁇ 4 3 ⁇ 4ife 1S-.4I0 dtes&s (l-sisisis&e, N.C, SEER Gaj3 ⁇ 4ar Sfsfeiks :ia3 ⁇ 41 ⁇ 2w ?
• W 75-2 ⁇ &5 lies LA.G, «t at., Editai Wad3 ⁇ 4i1 ⁇ 4 & is s* fsasA, sssssf ramsaacta nw, & af ⁇ damstel ⁇ 3 3 3 ⁇ 4 fatal esses i3 ⁇ 4
• feseliss models 8se mdd ee is -etpesied. to mt to 75&0 ⁇ is 2 ⁇ I5 5 . assd S J ⁇ 3 1 ⁇ 2 2IBS MA££S CD. assd ⁇ .
• fess .. frffes. is tmssx 3 ⁇ 4sslog ⁇ .1 GSSI3 ⁇ 4 «I_S?Q1, 23 ⁇ 4®.44 S ⁇ j ⁇ .19: t 3 ⁇ 4- 101..
• El-SsEEsg H..S iet al y lis castotisg 1 ⁇ 2 ⁇ r ⁇ se m. Hie nddESKse O£hqpafoaBiih$ ⁇ - swvmimia m &e Osafe. States: sa ⁇ eiate. Asss Iifes e j .2003. 3S 3 ⁇ 4: p.117-13) ou of fc riss- al eai-ses
• m tmsisssg aresis piiasaay Iks Ess ⁇ j ⁇ dfag 3 ⁇ 4s sssf I1 ⁇ 2s$ed!.
• l3 ⁇ 4s parses* wms&m. ye£ fcAer s ⁇ e!sles to a sse&ssl. &j? heaSiwg or prs sEtsg disease
• so-j- ii-1 ⁇ 2g s&ssHstssisg is :s sa&eei as «-3 ⁇ 4 ⁇ ii ⁇ .3 ⁇ 4 BS SSSSI: of: a isefsatfe E vjzsS t a&il feeases feat 1 ⁇ 2vdh?e mfefias s& a fee atfe 1 ⁇ 2as as m3 ⁇ 4ll as sS-erraial s eoss fal isiesl -He Mvsr.
• Saii asetkxis esm ise ⁇ $& & m3 ⁇ 4 «d: ss E&c&sn: .susKBst sf a. onaapcerai ear cm ⁇ osaism aoeaci1 ⁇ 2g is is psceseni wsm&s .
• a ⁇ 3 ⁇ 4 also isd le esf 3 ⁇ 4sa&-g asi &s ?eai g diseases: ⁇ sc£a3 ⁇ 4edi Sk isledim iA .a -se afe as, Ssr eosapie ⁇ aOftis A v ⁇ ls3 ⁇ 4s3 ⁇ fe B vinas, isepaii s C "sin3s ? fee aife: D liras* aa*i ia siife; E %1 ⁇ 2s$, ss ⁇ 3 ⁇ 43 ⁇ 4! as sUse ssses ihsdt. ix&ed ifae iisier 3 ⁇ 4 lias sess. fa* sos-psuu ⁇
• &s i-sdsss-iB act sigsaMssg: &H r ⁇ sslsmy kssmes AS , mFQ& a&d IO Q screw ⁇ - ⁇ , &E ⁇ $ ⁇ & ⁇ & ⁇ & wsMtfltiBtmte of &
• Dssi -sfei Eambers -of ca1 ⁇ 2i sfesjs (e.g. Cg ⁇ ) shall icier i-3g-e era$EE- to € e :sas-dbei srf I1 ⁇ 2M sicss-s m. . sfcd iiaaiefy sar t ⁇ £ e alkyl poxiism of a. lager l1 ⁇ 2s-l1 ⁇ 2s&sg
• 3 ⁇ 4S11 As Bsed lasss, ss iasssss "s ml" as ⁇ aSSyssssT gssa ⁇ S j . m1 ⁇ 2a#sr 3 ⁇ 4ss ; a&sse ear .as. 3 rt rf a sA ⁇ tsesi: 3 ⁇ 4 fe» ssdi tessdssl e3 ⁇ 43 ⁇ 46&. efasiks fcassg 2 as- eselbsm sfesm, grig-3 ⁇ 4ra3 ⁇ 4 ⁇ 2 ⁇ 2 ⁇ , i3 ⁇ 4iss£EEs ass.
• a-JkeByt sfeiai las si fast ess tmS. m 4as diais. s3 ⁇ 4 a3 ⁇ 4 ⁇ i dsam -aft least e3 ⁇ 4e aipls 3 ⁇ 4 ⁇ _3 ⁇ 41 m &g disk Jtlkssyl aiai alfcj ! gra-gss cm 3 ⁇ 4e
• 3 ⁇ 4i3 ⁇ 4fese3s1 ⁇ 2m grasps sssiSed i skaai ofs ' mktm sias-ss.. ssfoi fafie&.
• slss iselmk,. isar is as le., ⁇ 1 ⁇ 2 ⁇ ⁇ iss li3 ⁇ 43 ⁇ 4d, i1 ⁇ 2gs :&s3 ⁇ 4i m ⁇ i ⁇ se ar ISEKSS ssissesBd pss&ffi w mesa ex&xsi ⁇ ssms ssfifc amsse&s: w tx saiwsted w sstisliy sateratedi
• gjsssps ess be e ⁇ emsll m3 ⁇ 4sfciS-i «eiL msz ⁇ ,. ⁇ tifcl r * & ⁇ , ⁇ fa & ⁇ , axazelifcj :ls ⁇ ss$ ⁇ . sseao?n£ tfa ⁇ liisl, 1 ⁇ 2G$Mas33 ⁇ 43 ⁇ 4 i ⁇ Sasmfesi aatAm ⁇ ms ⁇ , ss-ssaisfcsas ,. l issis1 ⁇ 253 ⁇ 4
• P&lfji liss ism * 3 ⁇ 43 ⁇ 4SH ⁇ SE5'-, !> ⁇ & ⁇ & ⁇ assc. aksse «r as ar eff s-ss&es rsop.. is ⁇ &£mBd lassis as one mcee s1 ⁇ 2gs bavissg fesss.5 fas 2 ⁇ Scans 'sebeses. ai lea-si os3 ⁇ 4 sksm si Isasi SMS rissg is is bstsssaa l gpsa s that -ssfesdie 2 wwse fessi
• N or S a-tams is a fessearji cm he isS sL ns y3 ⁇ 4mfeww3 ⁇ 4>g s1 ⁇ 2 ⁇ i.
• sasss is fc 3 ⁇ 4 « 1 ⁇ 2Ss2 s; ⁇ ®il as isscWis-g fesse las- isEis grades. 3 ⁇ 4sa3 ⁇ 4k_. Fss- ⁇ snapis,
• ss i&ss ⁇ iisass mfetitesEfe exa is bc® tws Itf xogBS, atssss rat two adpacesi esrtssms ibsm ssM sdisi > ⁇ e nMy w6t F3 ⁇ 4r esass ⁇ k, a ss&sfefc&ed mrnf &s£ xeqmnes a skgfe %dtagg ⁇ afoot
• d ⁇ msmsaei-ayl is a safetsMsdi 33 ⁇ 43 ⁇ 4 to&wsmefe
• k X is k3 ⁇ 4lge3 ⁇ 4 m is -C3 ⁇ 4l Q33 ⁇ 4 -CF 3 ⁇ 4 OF -C3 ⁇ 4;
• .1 is .also msa1 ⁇ 2s£oo .
• &B se esoi isssMsgs memo a-ss all aosi BSS!£-S£ ⁇ pssesdaiss Imcsixi to &ess t s-few mm I ⁇ M y
• ⁇ Mssed LSTMte a safe CSE be fiemed wag ⁇ w ⁇ gsmc asisk W is&as- e, saife sas 3 ⁇ 4e £m-sd fern iise s& ⁇ ssg a sk ssaik. : pa oi-ss,. Iss&k,
• s partis y -or ® ⁇ ⁇ ⁇ 3 ⁇ 4 ⁇ 3 ⁇ 3 ⁇ 4 is jM ll As ' ei. tesss, 3 ⁇ 4 &3 ⁇ 43 & ⁇ &33 ⁇ 4' dii3 ⁇ 4di3 ⁇ 43 ⁇ 4' ⁇ ssid iS ei?ss 3 ⁇ 4 ase ** a mfeisass 3 ⁇ 43 ⁇ 4-
• pillf ht mum w ⁇ o ⁇ noessis ⁇ A ' is N
• Tible 1 Exms iaF sslndiissaets d ⁇ am sassls «f i1 ⁇ 2s feismsls ®:
• 13 ⁇ 4 s se&i msss& 3 ⁇ 4 ⁇ feer lelates o m msss Her e i1 ⁇ 2 fee iSG& a&ids sf & «sesl: -m3 ⁇ 4s&i-. isss sHSS-s s£ fee 5s3 ⁇ 4seHi teadaigs eas. be p2s a ⁇ &i 1 ⁇ 2 asacrfsiBse 3 ⁇ 4A fee is. fee Hfee fesie. isaj&hrfHBpaiTe is gxBe&abes, hf *gosp i$mg sSansl-ffiS- sysissiie ssefeods
• ess desciifesat 1 ⁇ 2_3 ⁇ 4 ⁇ 2.
• ess be eamsi «E& m sm3 ⁇ 4a3 ⁇ 4fe satesis QD fee :s3 ⁇ 4ss!% ! sekdsd %
• esse skiisi is ifc as* rf ss esk;. sf&fa s.
• PIJJJ T a. sismsi sas a3 «m a£ I- msc-3->fe3 ⁇ 41 ⁇ 23J1 ⁇ 2-3-yI)&i -i3 ⁇ 42 £6j3Q g resort 15.9 jmaat) m diE ssssE-g&ssss ( S s-L), m'ss s kfe! jsipeiisiEss: (24 H_L ⁇ legal 11» rssdsm nsBdssrg: TOSS sfe3 ⁇ 4sl si rasas temg* t ⁇ 3 ⁇ 4 fa 20 hams, aad Site*®!
• g ⁇ dffle-2- €ai3 ⁇ 4G ⁇ k add is i3 ⁇ 4 same -am ss ss Exam le 17 to s3 ⁇ 43 ⁇ 4!e- ttie mdxsd .as
• PlCfeJ T « a sds&ss df2nsK3 ⁇ 4Bis3 ⁇ 45a3 ⁇ 4si3 ⁇ 4B (2-42 g, 20 S£ESSI m a mss3 ⁇ 4se ⁇ £41% ⁇ i ⁇ me add p.3sS :mL, IBE) asd asefe s d £22 IBL) a ⁇ * C., was siied dss ⁇ s ass- Issaneme I. IS EBL, 22 BDSSO ⁇ L Use isactks- Hiaefcii-S is s sfasd a rosm.
• ,/ ?J 3 ⁇ 4 l3 ⁇ 4 C3 ⁇ 4m?J41 ⁇ 4
• P2MJ 5-Mm ⁇ 2-y ⁇ - ⁇ 2-- ⁇ -2-ws x was syn&esmBd femi 2;- p ⁇ s3 ⁇ 43 ⁇ 4is iss ra&d as 3 ⁇ 4 sa er- siy sdl 3 ⁇ 4 M R (300 3 ⁇ 4J3 ⁇ 4 03 €3 ⁇ 4 ⁇ : S f .70 (s, IB. M3 ⁇ 4. &£ ft.
• s stl-essassl fern ( ⁇ g -3 ⁇ 4 ⁇ -33 ⁇ 4-2- ⁇ a&d iH-f k: ac is S3 ⁇ 4g ssKie auser as E&assspls 9 Is
• AH ssei ,sst wasf il 3 role as dsaple tw&.&i being ass. fUsr, ear :as_ es-eipasaafr as ase Isese&!msf be psrt of s pH is ssssg. sestets OK essfag 1 ⁇ 2 _ES$H « dsfc&y ssf fts sgjafesssfe saMf fes- ti s stasask. Us fssimi!ster eaa s!sss tals s& ⁇ ss-isgg sf fee £k& &s csss s Siiis af
• PlSff llsefii isfc fo si siKms « be msde by Oa w& sl pse e®, wet
• ssc sMi cites, ⁇ Es ies, silk&te cafciiss emfe- fe, ⁇ dm ⁇ as R, sssttsl, iio ⁇ te., cslcism sulfate, lactase., k&ofe S SMtoI, c orifc lo MeJt.i3 ⁇ 4g; i ioa e3 ⁇ 4e&s& ⁇ e rssias. Smites laod ⁇ mg ag ats ms tds ® m®mc .m SMMIC
• rn gfcr acta l &aiimcmiicsl sdditiws &adi as solb iisesrs, TM ⁇ 3 ⁇ 4 3 ⁇ 4 teflta, imM, e m ⁇ fconog: ge ⁇ ⁇ &i .gats.
• sii c i aiHiig additives si dicrifei kerei-3 ⁇ 4 g.g ., ssseb. as $ i cslslose ⁇ ®ki&s1 ⁇ 4l ; ateofasits ( ⁇ fe sg mah ⁇ kk;. kksh wd k sloitsk, e.g., g ⁇ ls as fcr d ⁇ is (e.g.., feet-omied ⁇ accus-i ean -a .
• rsbly me tsmssogaAcm cssafK ⁇ iim is m. -waa dosage Mas, tor
• ir sssj be essim s to ad-nimsier a CMi srf diiecS to & arsOTS of He fe ⁇ tisag fe-ices ssscli as, ls.it w& faifed
• i_iwfcg sit ij ⁇ &olx3 ⁇ 4i3 ⁇ 4 or sag sss-fel.
• P273J 13 ⁇ 4 ltrnmasssikssl ⁇ s m m tsMe ir mjgsfcs cm issMe ⁇ sdle aspssass teet as&e iesmsm or US liscosii pazoits ii to S ⁇ w tiiosigii a %iisge.
• sat stom el ct-i be fresersasi ags si lie csHi ai iisg seikm
• WW C i k taiM boon cm be ⁇ ⁇ or s fee
• teadaBgs csB be a&tmsteBct altsse *r k sm3 ⁇ 41 ⁇ 23&m wi& e-tbs efiedwe f»I Hn m0&ig somite of npfflsifKns arcadmg to &e KHB*
• 3 ⁇ 4M 2 f-ke laiy eel if scrsesmg; SSSHIIS fo OTB odf of fee di lofia-e

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Virology (AREA)
• Oncology (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Communicable Diseases (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Molecular Biology (AREA)
• Hematology (AREA)
• Gastroenterology & Hepatology (AREA)
• Biotechnology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
• Thiazole And Isothizaole Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Priority Applications (13)

Applications Claiming Priority (2)

Related Child Applications (2)

Publications (1)

Family

ID=48044139

Family Applications (1)

Country Status (13)

Cited By (8)

Families Citing this family (8)

Citations (3)

Family Cites Families (6)

• 2012
  • 2012-10-04 SG SG11201401207XA patent/SG11201401207XA/en unknown
  • 2012-10-04 BR BR112014007963A patent/BR112014007963A2/pt not_active IP Right Cessation
  • 2012-10-04 EP EP12838333.8A patent/EP2763674A4/en not_active Withdrawn
  • 2012-10-04 PH PH1/2014/500724A patent/PH12014500724A1/en unknown
  • 2012-10-04 WO PCT/US2012/058674 patent/WO2013052613A1/en not_active Ceased
  • 2012-10-04 AU AU2012318670A patent/AU2012318670B2/en not_active Ceased
  • 2012-10-04 US US14/349,014 patent/US20140249154A1/en not_active Abandoned
  • 2012-10-04 CA CA2850779A patent/CA2850779A1/en not_active Abandoned
  • 2012-10-04 HK HK15101053.5A patent/HK1200361A1/xx unknown
  • 2012-10-04 CN CN201280059490.1A patent/CN103957908A/zh active Pending
  • 2012-10-04 KR KR1020147011691A patent/KR20140071472A/ko not_active Ceased
  • 2012-10-04 JP JP2014534680A patent/JP6240078B2/ja not_active Expired - Fee Related
• 2014
  • 2014-04-03 IL IL231923A patent/IL231923A0/en unknown
• 2016
  • 2016-09-07 US US15/258,393 patent/US10087173B2/en not_active Expired - Fee Related
• 2017
  • 2017-04-13 JP JP2017079817A patent/JP2017149753A/ja not_active Withdrawn

Patent Citations (3)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events